Influences of blood lipids on the occurrence and prognosis of hemorrhagic transformation after acute cerebral infarction: a case-control study of 732 patients

Table 8 Adjusted logistic analysis for risk factors of HT

Item	B	df	Adjusted OR	95% CI		P value
Item	B	df	Adjusted OR	Lower	Upper	P value
Age		2				0.727
Age (1)	−0.209	1	0.811	0.341	1.930	0.636
Age (2)	−0.006	1	0.994	0.403	2.451	0.989
Sex	0.144	1	1.155	0.674	1.978	0.600
DM	0.476	1	1.609	0.959	2.699	0.072
AF	0.687	1	1.989	1.089	3.632	0.025
SBP	0.000	1	1.000	0.989	1.012	0.937
Hypoproteinemia	-0.201	1	0.818	0.408	1.641	0.572
Site	−0.563	1	0.569	0.297	1.093	0.090
Size		2				0.000
Size(1)	1.670	1	5.310	2.581	10.925	0.000
Size(2)	1.968	1	7.158	3.020	16.962	0.000
Cortex	0.734	1	2.083	1.024	4.236	0.043
TC		2				0.020
TC (1)	−1.025	1	0.359	0.136	0.944	0.038
TC (2)	−0.191	1	0.826	0.223	3.057	0.775
TG		2				0.874
TG (1)	0.264	1	1.303	0.474	3.582	0.609
TG (2)	0.284	1	1.328	0.408	4.329	0.638
HDL		2				0.393
HDL (1)	0.421	1	1.524	0.680	3.418	0.306
HDL (2)	−0.291	1	0.747	0.140	3.993	0.733
LDL		2				0.368
LDL (1)	0.313	1	1.367	0.608	3.075	0.449
LDL (2)	−0.131	1	0.877	0.349	2.207	0.781
Anti-PLT		3				0.058
Anti-PLT (1)	−0.327	1	0.721	0.340	1.528	0.393
Anti-PLT (2)	0.558	1	1.747	0.959	3.182	0.068
Anti-PLT (3)	0.609	1	1.838	0.748	4.520	0.185
rTPA	−0.022	1	0.978	0.492	1.945	0.950
Constant	−3.074	1	0.046			0.012

METHOD = ENTER, Entry = 0.05, Removal = 0.10; Age. 0 < 50, 1 = 50 to 70, 2 > 70 years; Sex. 0 = F, 1 = M; DM Diabetes mellitus, AF Atrial fibrillation, SBP Systolic blood pressure; Site. 0 = Anterior, 1 = posterior circulation; Size. 0 = small, 1 = middle, 2 = large of infarction; Cortex. 0 = untouched, 1 = involved; TC. Total cholesterol, 0 = lower than normal, 1 = normal, 2 = higher than normal; Anti-PLT. Platelets, 0 = no, 1 = aspirin 100 mg or clopidogrel 75 mg, 2 = aspirin 100 mg + clopidogrel 75 mg, 3 = aspirin 300 mg or clopidogrel 300 mg; TG Triglyceride, HDL High density lipoprotein cholesterol, LDL Low density lipoprotein cholesterol, rTPA Recombinant human tissue plasminogen activator

ISSN: 2054-9369